Novo Nordisk - Red Flags of Alzheimer's

Novo Nordisk is on the cusp of launching their new indication for semaglutide in Alzheimer's Disease, which can be effective in slowing the onset of disease - but only if Alzheimer's is identified and treated early.

The brief for this campaign was to encourage higher recognition of the potential early signs of Alzheimer's Disease in both people with the condition and with caregivers.

The idea was focused around how Alzheimer's slowly creeps up on people, starting with little oddities that could just be signs of ageing. It encourages people to take notice of their loved ones, because while these funny things could be signs of aging - it could be Alzheimer's.